De Burlo Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,955
| Closed | -$426K | – | 79 |
|
|
2024
Q4 | $426K | Sell |
4,955
-143,775
| -97% | -$12.4M | 0.06% | 69 |
|
|
2024
Q3 | $17.7M | Sell |
148,730
-23,850
| -14% | -$2.84M | 2.18% | 20 |
|
|
2024
Q2 | $24.6M | Buy |
172,580
+49,564
| +40% | +$7.07M | 3.31% | 12 |
|
|
2024
Q1 | $15.8M | Buy |
+123,016
| New | +$15.8M | 2.1% | 22 |
|
|
2022
Q4 | – | Sell |
-6
| Closed | -$299 | – | 153 |
|
|
2022
Q3 | $299 | Sell |
6
-471,702
| -100% | -$23.5M | ﹤0.01% | 189 |
|
|
2022
Q2 | $26.3M | Buy |
+471,708
| New | +$26.3M | 7.49% | 5 |
|